Washington, DC: Ogilvy PR and Shire Health Group have created Fast4wD Ogilvy, a clinical trial recruitment and retention firm.
The firm, aiming at the pharmaceutical companies that need global clinical trial support, will combine Ogilvy PR's Washington office with the European and Asian capabilities of Shire's Fast4wD UK's.
Fast4wD Ogilvy will maintain offices in Washington, DC, and Oxford, UK. Emma Sergeant, managing director of Fast4wD UK will serve as president worldwide of Fast4wD Ogilvy. Chris Shreeve, Ogilvy SVP, will head up the Washington office. Michelle Argument will head the Europe/Asia office out of Oxford. Ogilvy does not yet know how many full-time employees it will devote to the joint practice, Shreeve said.
Fast4wD UK cannot disclose its clients, due to contractual agreements, but Sergeant said the firm represents six clients of the top ten global pharmaceutical companies.
Fast4wD Ogilvy has already pitched to two major global pharmas, and expects to hear back from them this week, Sergeant said.
Shreeve said that while there were a few competitors in the US space, none could offer the global solutions that Fast4wD Ogilvy could offer.
Fast4wD pharmaceutical clients said to [the firm], "You're great, but why don't you get a US presence?" Shreeve said.
She added: "We're all part of the [Ogilvy] network and Fast4wD was impressed by Ogilvy's health communications."
Ogilvy had not had a practice devoted to clinical trials before, but had done some trial work for government clients, Shreeve said, adding that many Ogilvy practitioners had previous experience in clinic trials.
"Sometimes our clients needed clinical trial recruitment and we've always been calling on this expertise," she said, adding that the new firm allowed Ogilvy to announce its commitment to competing for that work.